FDA Recalls Some Valsartan Drugs Due to Impurity
July 16, 2018 -- The FDA has announced a voluntary recall of several drugs that contain the heart drug valsartan because a possible carcinogen was found in the recalled products. NDMA, which was found in the valsartan products, could cause cancer, ...
